Lupin and Zentiva partner to commercialize Certolizumab Pegol biosimilar globally, sharing profits and investing in ...

Medicare covers Dovonex — the brand name for the medication calcipotriene — when it’s medically necessary. Read more.

Halobetasol (Lexette, Ultravate, Bryhali ) is a corticosteroid drug for treating plaque psoriasis. The brand Lexette is a topical ... One can of Lexette can cost nearly $1,000 without insurance. If a ...

Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...

Ilumya (tildrakizumab-asmn) is a prescription injection that treats plaque psoriasis in adults. Learn about Ilumya's dosage, side effects, and more.

Global Pharma major Lupin Limited and Zentiva Group, a pan-European pharmaceutical company, have entered into a license and ...

Inspired by feedback from the hidradenitis suppurativa (HS) community, the campaign aims to raise awareness of BIMZELX and features a broad range of ...

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...

Pharma major Lupin Ltd on Wednesday said it has inked a license and supply pact for commercialisation of its biosimilar 'Certolizumab Pegol' across multiple global markets with the Zentiva Group, ...

In 2022, the FDA approved deucravacitinib as a first-in-class, oral, selective TYK2 inhibitor for adults with moderate to severe plaque psoriasis. 2 Based on results from the phase 3 POETYK PSO-1 ...